Related Experiment Videos
Erythrocyte lipid abnormalities in Reye's syndrome
Pediatric Research
|April 1, 1987
Summary
Reye's syndrome (RS) alters erythrocyte membrane lipids, increasing polyunsaturated fatty acids and cholesterol. These changes, linked to viral illness and aspirin, are temporary and resolve upon recovery.
Area of Science:
- Biochemistry
- Pediatrics
- Neuroscience
Background:
- Reye's syndrome (RS) is associated with altered plasma free fatty acids.
- Erythrocyte membrane lipid modifications in RS require further investigation.
Purpose of the Study:
- To investigate structural and functional changes in erythrocyte membrane lipids in children with Reye's syndrome.
- To compare lipid profiles between Reye's syndrome patients and critically ill intensive care unit (ICU) controls.
Main Methods:
- Erythrocyte lipids were measured in children with RS and ICU controls.
- Key lipids analyzed included phospholipid arachidonate, polyunsaturated/saturated fatty acid ratios, cholesterol, and malondialdehyde generation.
Main Results:
- Comatose RS patients showed a 2-fold increase in erythrocyte phospholipid arachidonate compared to ICU controls.
- RS patients exhibited a higher ratio of erythrocyte phospholipid polyunsaturated/saturated fatty acids and increased erythrocyte cholesterol.
- Decreased erythrocyte malondialdehyde generation was observed in RS patients.
Conclusions:
- Erythrocyte membrane lipid alterations in Reye's syndrome are transient and linked to viral infection and/or aspirin use.
- These findings suggest that observed biochemical abnormalities are not due to intrinsic lipid metabolism differences.
- Recovery from RS led to the normalization of erythrocyte lipid profiles.